Details for Patent: 10,765,640

Which drugs does patent 10,765,640 protect, and when does it expire?

Patent 10,765,640 protects ZTLIDO and is included in one NDA.

This patent has twenty-three patent family members in eighteen countries.

Summary for Patent: 10,765,640

Title:	Non-aqueous patch
Abstract:	[Problem] If lidocaine is composed of non-aqueous patch, the adhesive power of the preparation tends to get lower, as the composition amount of lidocaine is higher. It is popular to solve lidocaine in dissolving agent in order to compose lidocaine in patch and release effective amount into skin. However, if the amount of dissolving agent gets higher, the adhesive power gets extremely lower, so that an long-time attachment is difficult. [Solution] A non-aqueous patch comprising lidocaine and/or its reactant, and a dissolving agent which are contained in a base of plaster, the plaster being hold by a support, of which strength of 50% stretched to longitudinal direction is less than 2,000 g/50 mm and of biaxially-oriented stretch cloth.
Inventor(s):	Mori; Tatsuya (Saga, JP), Saida; Naoyuki (Saga, JP)
Assignee:	ITOCHU CHEMICAL FRONTIER Corporation (Tokyo, JP) OISHI KOSEIDO CO., LTD. (Saga, JP)
Application Number:	14/346,794
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 10,765,640

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Scilex Pharms	ZTLIDO	lidocaine	PATCH;TOPICAL	207962-001	Feb 28, 2018		RX	Yes	Yes			Y

Foreign Priority and PCT Information for Patent: 10,765,640

PCT Information
PCT Filed	September 27, 2011	PCT Application Number:	PCT/JP2011/072072
PCT Publication Date:	April 04, 2013	PCT Publication Number:	WO2013/046335

International Family Members for US Patent 10,765,640

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Brazil	112014006719
Canada	2850024
Cyprus	1120754